Aristides Capital’s Daxor DXR Stock Holding History

Aristides Capital’s Portfolio DXR Stock Details DXR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$429K	Sell	41,689 -3	-0%	-$30	0.08%	133
2026 Q1	$403K	Buy	+41,692	New	+$508K	0.09%	111

Other funds holding DXR

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

NCNMGF

Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Aristides Capital's DXR Position: Q2 2026 in Review

Aristides Capital reduced its Daxor (DXR) stake by 0.01% in Q2 2026, selling an estimated $30 and leaving 41,689 shares worth $429K. The position accounts for 0.08% of the portfolio, ranked #133.

Aristides Capital first reported a position in DXR in Q1 2026 and has held it in 2 quarters since. 14 funds tracked by Wall St. Rank hold DXR as of Q2 2026.

Aristides Capital held 41,689 shares of Daxor worth $429K as of Q2 2026.
Aristides Capital sold 3 Daxor shares in Q2 2026, an estimated $30.
Daxor made up 0.08% of Aristides Capital's portfolio in Q2 2026, its #133 holding.
Aristides Capital first reported a position in Daxor in Q1 2026 and has held it in 2 quarters since.
14 funds tracked by Wall St. Rank held Daxor as of Q2 2026.

Based on Aristides Capital's 13F filing for Q2 2026, filed 13 Aug 2026.